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Abstract
Background: Recognition of cardiovascular (CVD) risk profile and its 
patterns at the time of diagnosis of diabetes would enable adoption 
of most appropriate primary prevention strategies to reduce morbidity 
and mortality from vascular disease. We aimed to study the prevalence 
and pattern of modifiable CVD risk factors in patients at the time of 
diagnosis of type 2 diabetes.  
Methods: In this  single center, cross sectional study,  412 newly 
diagnosed patients with type 2 diabetes were studied on prevalence 
of low density lipoproteins (LDL), triglycerides (TG), high density li-
poproteins (HDL) and systolic and diastolic blood pressure (SBP and 
DBP) . Prevalence of each risk factor was determined according to the 
American diabetes association criteria. Associations of each risk factor 
(dependent variable) with gender, age at onset of diabetes, waist cir-
cumference (WC) and body mass index (BMI) (independent variables) 
were studied using logistic regression. 
Results: Males accounted for 71% of sample and Mean (SD) age 
49(11) years. The most prevalent lipid abnormality was LDL > 100 mg 
(81%) and low HDL and raised TG were detected in 17.1%, 18.5%. 
SBP> 140 mm Hg and DBP > 90 mm Hg were prevalent in 15% and 
12%. Male gender (odds ratio 7.98; 95% confidence interval 4.39 
to14.49) and younger age at onset of diabetes (odds ratio 0.95; 95% 
confidence interval 0.93  to 0.98) were significantly associated with 
lower HDL. The younger age was significantly associated with adverse 
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Introduction
Cardio-vascular diseases (CVD) contribute sub-
stantially to morbidity and mortality among indi-
viduals with type 2 diabetes (T2DM)(1). Dyslipidem-
ia and hypertension are the major modifiable risk 
factors for this increased predilection (2). Lifestyle 
modifications and pharmacological interventions 
targeted at reducing blood pressure and altering 
adverse lipid profile have shown to reduce cardio-
vascular morbidity and mortality among individuals 
with T2DM(3,4).  
Type 2 diabetes affects individuals in all age 
groups; the young, middle and elderly and also 
those with both lean and obese body habitus. Car-
diovascular risk profile of an individual with diabetes 
is known to vary according to several factors includ-
ing ethnicity and gender (5,6).  Studies conducted 
in multi ethnic settings revealed that individuals of 
South Asian ethnicity possess more adverse CVD 
risk factor profile and they succumb to cardiovas-
cular diseases prematurely as compared to Cauca-
sians(7). With rising burden of T2DM in South Asia, 
knowledge on the prevalence, pattern and associa-
tions of modifiable CVD risk factors in patients with 
newly diagnosed diabetes would enable clinicians 
to pay more attention on those with higher CVD 
risk. Implementation of targeted primary prevention 
strategies and management protocols could poten-
tially delay or prevent adverse cardiovascular out-
comes in patients with T2DM. 
There is paucity of data on the prevalence of ma-
jor modifiable risk factors and their variations ac-
cording to gender, age at onset and type of obesity 
in patients with newly diagnosed T2DM in Sri Lan-
ka. We aimed to study the prevalence and pattern 
of modifiable CVD risk factors including major lipid 
fractions and systolic and diastolic blood pressure 
in patients with newly diagnosed  T2DM and to 
detect possible association of these risk factors with 
gender, age at onset of diabetes, central obesity 
(measured as waist circumference) and global obe-
sity (measured as body mass index). 
Methodology
This was a cross sectional study. We analyzed 
a database which included demographic, clinical 
and biochemical data of patients who underwent 
TG levels (odds ratio 0.95;95% confidence interval 0.93 to 0.95). Sig-
nificant associations were detected with SBP and DBP with age (odds 
ratio 1.09; 95% confidence interval 1.05 to 1.13) and odds ratio 1.062; 
95% confidence interval 1.006 to 1.121) respectively. 
Discussion: Adverse LDL levels are present in 8 out of 10 patients 
at the time of diagnosis of diabetes. Modifiable CVD risk factors vary 
according to the age at onset of diabetes with more atherogenic dys-
lipidemia prevalent in younger and elevated blood pressure in older 
patients.
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screening in a diabetes clinic at the time of first 
diagnosis of type 2 diabetes before commencing 
any hypoglycemic, anti -hypertensive or lipid lower-
ing therapy. Ethical approval for the study was ob-
tained from the local Ethics review committee. Data 
on their demographic (gender, age) clinical (height, 
weight, waist circumference, systolic and diastolic 
blood pressure) and biochemical (total cholesterol, 
low density lipoproteins, triglycerides, high density 
lipoprotein levels) parameters were analyzed. Opti-
mal cutoff levels for blood pressure and lipids rec-
ommended by the American diabetes association 
(ADA) were used to determine the prevalence of 
each cardiovascular risk factor needing therapeutic 
intervention(8).  The proportions with systolic blood 
pressure ( SBP> 140 mm Hg), diastolic blood pres-
sure ( DBP>90 mm Hg) ,  low density lipoprotein 
level ( LDL > 100 mg/ dL) , triglycerides( TG> 150 
mg/ dL) and high density lipoprotein level ( HDL < 
40 mg/ dL in males and < 50 mg/ dL in females) 
were estimated in the whole sample. 
Statistical analysis 
All numerical data were represented as mean (SD) 
and categorical data as percentages. Comparison of 
percentages with each individual CVD risk factors 
above the recommended level was carried out with 
chi2 test. Logistic regression analysis was used to 
study the association of age, gender, BMI and waist 
circumference with each of the modifiable cardio-
vascular risk factor. Age adjusted odds ratios were 
calculated for each risk factor and level below 0.05 
was taken as statistically significant.  
Results 
There were 412 patients with a majority (71%) 
of males. The mean age (SD) and BMI (SD) were 
44 (11) years and 24.5(3.3) kg/ m2 respectively. The 
most frequently detected modifiable CVD risk fac-
tor was elevated LDL cholesterol level over 100 mg / 
dL which was found in 81% of participants. Subop-
timal levels of TG and HDL was found in 18.5% and 
17.1 % of patients. Descriptive data of the study 
participants are shown in table 1. 
To study gender variations of modifiable cardio-
vascular risk factors, we compared the mean values 
of  each risk factor in males and females included 
in the sample (table 2) .
Females had higher age adjusted mean SBP and 
DBP and males had lower mean HDL levels. Mean 
levels of total cholesterol, LDL and triglycerides did 
not show any significant difference. 
We carried out logistic regression analysis to study 
the association of each modifiable CVD risk factor 
(LDL > 100 mg/ dL, TG > 150 mg / dL and HDL < 
50 mg / dL in females and < 40 mg / dL in males 
and SBP ≥ 140 mm Hg and DBP ≥ 90 mm Hg) as the 
dependent variables and four clinical variables (gen-
der, age at diagnosis, waist circumference (WC) and 
body mass index (BMI)) as independent variables. 
Results of analysis of each CVD risk factors are 
Table 1.  Descriptive data of the patients with 
diabetes (n=412).
Factor Percentage 
Age(years)* 49 (11)
Gender (male) 71.3%
BMI (kg/m2)* 24.5 (3.3)
WC (cm)* 91.1 (8.9)
SBP (mmHg)) 122 (15)
DBP (mmHg)) 77 (9)
TC (mg/dL)* 208.1 (35.5)
HDL (mg/dL)* 49.4 (7.7)
LDL (mg/dL)* 133.3 (34.1)
TG (mg/dL)* 120.8 (53.7)
Proportion of suboptimal HDL 17.1%
Proportion of suboptimal LDL 81.2%
Proportion of suboptimal TG 18.5%
* given mean (SD)
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shown in tables 3 - 6. 
Males had higher odds of having LDL above 100 
mg/ dL but it was not statistically significant. None of 
the other three clinical parameters studied showed 
a statistically significant association with elevated 
LDL cholesterol level over 100 mg / dL.
Of the four clinical variables, younger age and 
male gender had significantly higher odds ratios for 
low HDL. Although higher BMI was found to have a 
significant association with lower HDL levels, lower 
WC also showed a significant association with low-
er HDL cholesterol in this cohort. 
Serum TG level above 150 mg / dL was signifi-
cantly associated with younger age. None of the 
other three clinical variables had significant associ-
ation with triglyceride level above 150 mg/dL. 
Table 3.  Association between clinical variables 
and high LDL 
Clinical risk factor Odds ratio (95% CI) P value
Age at diagnosis 1.003 (0.98 to 1.03) 0.84
Gender (male) 2.46 (1.19 to 5.07) 0.15
WC 0.98 (0.93 to 1.03) 0.4
BMI 0.99 (0.87 to 1.12) 0.86
Table 4.  Association between clinical variables 
and low HDL 
Clinical risk factor Odds ratio (95% CI) P value
Age at diagnosis 0.95 (0.93 to 0.98) <0.01
Gender (male) 7.98 (4.39 to 14.49) <0.01
WC 0.95 (0.91 to 0.99) 0.03
BMI 1.139 (1.077 to 1.288) 0.04
Table 5.  Association between clinical variables 
and high TG 
Clinical risk factor Odds ratio (95% CI) P value
Age at diagnosis 0.95 (0.93 to 0.98) <0.01
Gender (male) 0.73 (0.39 to 1.36) 0.32
WC 1.02 (0.98 to 1.07) 0.36
BMI 1.003 (0.888 to 1.133) 0.96
Table 6.  Association between clinical variables 
and elevated SBP 
Clinical risk factor Odds ratio (95% CI) P value
Age at diagnosis 1.09 (1.05 to 1.13) <0.01
Gender (male) 1.16 (0.53 to 2.55) 0.71
WC 0.98 (0.92 to 1.04) 0.53
BMI 1.02 (0.86 to 1.20) 0.82
Table 2. Gender variations of mean values of each risk factor adjusted for age and BMI 
Factor
Male
mean (SD)
Female
mean (SD)
P value*
SBP (mmHg) 120 (14) 124 (17) 0.03
DBP (mmHg) 77 (8) 79 (9) 0.02
TC (mg/dL) 207.5 (37) 209.4 (31.6) 0.63
HDL (mg/dL) 48.6 (7.6) 51.2 (7.9) <0.01
LDL (mg/dL) 131.5 (37) 134.5 (32.8) 0.43
TG (mg/dL) 123.2 (55.4) 115.0 (49.0) 0.16
*student t test 
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Table 7.  Association between clinical variables 
and elevated DBP 
Clinical risk factor Odds ratio (95% CI) P value
Age at diagnosis 1.062 (1.006 to 1.121) 0.03
Gender (male) 1.28 (0.39 to 4.11) 0.68
WC 1.01 (0.92 to 1.11) 0.86
BMI 0.98(0.76 to 1.25) 0.86
Higher age at diagnosis was found to be signif-
icantly associated with SBP over 140 mm Hg. Al-
though male gender and higher BMI showed higher 
odds of having SBP over 140 mm Hg none of them 
were statistically significant. 
Out of the four parameters only the age at di-
agnosis showed statistically significant association 
with diastolic blood pressure over 90 mm Hg. 
Discussion 
Findings of this study reveal that there is a high 
prevalence (81. 2 %) of adverse level of LDL choles-
terol (over 100 mg / dL) at the time of diagnosis of 
diabetes. Although more males had LDL above 100 
mg/ dL than females, no significant gender variation 
was observed.  But male gender was associated 
with significantly higher odds of having lower HDL 
cholesterol level. Mean levels of SBP and DBP were 
significantly higher in females and mean HDL lev-
els were significantly lower in males.   Males with 
newly diagnosed T2DM compared to females have 
non-significantly higher odds of possessing all major 
modifiable CVD risk factors except higher TG level. 
Of the clinical parameters, younger age at onset 
of diabetes revealed a significant association with 
higher TG and lower HDL cholesterol levels.  BMI 
revealed a positive association with SBP, TG and low 
HDL but a statistically significant association of BMI 
was only seen with lower HDL cholesterol level.
Gender variations of cardiovascular risk factors 
among patients with diabetes reported in previous 
studies reveal a comparatively adverse risk profile 
amongst females(9). This has been postulated as a 
possible cause for higher cardiovascular morbidity 
and mortality in females with diabetes.  Our study 
included a majority (71%) of males and we found 
higher mean levels of SBP and DBP levels in females 
and lower HDL in males. Relatively lower propor-
tion of females (29%) included in this study sample 
could have affected these results.
According to studies conducted in multi ethnic 
settings, there are significant variations in the prev-
alence and pattern of CVD risk factors among indi-
viduals with diabetes (10). A meta-analysis of lipid 
parameters of  24, 000 subjects has reported that 
Asian Indians with and without diabetes compared 
to Caucasians and Chinese have significantly higher 
odds of lower HDL cholesterol and higher TG lev-
els(11). They also reported significantly lower HDL 
cholesterol in males compared to females of Asian 
Indian ethnicity. A study conducted in multiethnic 
population in the United Kingdom have revealed 
comparatively worse lipid profiles with lower HDL 
cholesterol levels and higher CVD event rate among 
the South Asians compared to Caucasians(7). A 
study conducted in Singapore among patients with 
type 2 diabetes from different Asian ethnicities have 
reported  that Asian Indians have significantly low-
er HDL cholesterol levels compared to Malays and 
Chinese patients(12).  One  previous study of 592 
patients with newly diagnosed T2DM conducted in 
Sri Lanka has reported similar prevalence of high TG 
(14%) and low HDL (12%) but they do not report 
on the prevalence of high LDL among the study 
participants (13). 
Pattern of dyslipidemia especially the high preva-
lence of adverse LDL cholesterol levels in more than 
80% of individuals with diabetes at the time of di-
abetes in this study has several management impli-
cations. It is well established that adverse levels of 
LDL cholesterol is strongly associated with all types 
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of CVD including coronary artery disease (CAD) , 
cerebrovascular disease (CVD) and peripheral artery 
disease (PAD). American diabetes association advo-
cates that the optimal level of LDL cholesterol to 
prevent CVD in patients with diabetes should be 
less than 100 mg / dL. Therefore, based on the 
single risk factor modification approach, findings of 
this study would compel clinicians to start statin 
therapy for 80% of patients at the time of diagnosis 
of T2DM. However, with the introduction of total 
cardiovascular risk management approach, there is 
a tendency to avoid commencement of pharma-
cotherapy based on a single risk factor. Total CVD 
risk management approach recommends initiation 
of pharmacotherapy such as statins or aspirin based 
on the category (low, moderate or high) of cardio-
vascular risk of the individual. The latter is calculated 
using an appropriate chart or a score such as Fram-
ingham risk chart or United Kingdom prospective 
diabetes study (UKPDS) risk engine respectively.       
Most studies on the epidemiology of lipids among 
individuals with newly diagnosed diabetes are con-
ducted in the Caucasians and they have shown that 
LDL cholesterol levels in the diabetic sub population 
are not significantly different from the non-diabetic 
subjects. Mean LDL cholesterol levels in the newly 
diagnosed males and females with T2DM recruited 
for the UKPDS was 139 and 153 mg/ dL (p=<0.05) re-
spectively(14). Newly diagnosed patients with T2DM 
in this study revealed similar mean LDL cholesterol 
level (133 mg/ dL), but unlike in UKPDS study which 
showed significantly higher mean LDL cholesterol 
in females, more male patients had adverse LDL 
cholesterol in this study. Observation of more than 
80% having higher levels of LDL in this study could 
be due to the lower cut off limit used to define the 
undesirable LDL cholesterol according to the recent 
guidelines. Lower prevalence rates of adverse LDL 
cholesterol levels in some previous studies could be 
due to the higher cut-off levels used to categorize 
adverse level of LDL cholesterol according to older 
guidelines. 
This study also revealed a statistically significant 
association of younger age at onset of diabetes 
with higher TG levels (OR - 0.95, CI 0.93 to 0.98, p 
< 0.01) and lower HDL (OR - 0.95, CI 0.93 to 0.98, 
p< 0.01). High TG level and low HDL cholesterol 
level is a surrogate marker of insulin resistance and 
is also considered as a hall mark of atherogenic dys-
lipidemia (15). Studies using TG/ HDL ratio as the 
Atherogenic plasma index (API) have shown that it 
correlate positively with carotid intima media thick-
ness (CIMT), a  surrogate marker of atherosclerosis 
(16).
Finding of atheogenic dyslipidemia among the 
younger age at onset of T2DM has several impli-
cations. Although statin therapy reduces elevated 
LDL cholesterol with clinically significant reductions 
in all forms of CVD, to date, attempts to find a safe 
and effective pharmacological agent to raise low 
HDL levels which lead to favorable clinical outcomes 
have not been very successful (17). In the absence 
of a safe and effective pharmacotherapy to opti-
mize atherogenic dyslipidemia, clinical guidelines 
emphasize the importance of non-pharmacological 
interventions to achieve favorable HDL cholesterol 
(15). Findings of this study emphasize the need for 
implementation of intensive non-pharmacological 
approaches aimed at optimizing the atherogenic 
lipids for younger patients with diabetes from the 
time of diagnosis of diabetes.  
High blood pressure, defined as systolic and blood 
pressures over 140 and 90 mm Hg, were found to 
be less prevalent (12-15%) than the adverse lipids 
(80%) among subjects with diabetes in this study. 
The prevalence of hypertension in this study is lower 
than the reported prevalence of hypertension in the 
population. A nationwide study in a sample of 5000 
people conducted in 2005  had revealed 23% prev-
alence of hypertension (18). The lower prevalence 
of hypertension among newly diagnosed patients 
with diabetes could be due to the relatively more 
number of younger patients with diabetes included 
in our sample and the smaller sample size. As with 
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adverse lipids, male gender was associated with 
non-significant, higher odds of having both systolic 
and diastolic blood pressure in this study. Of the 
clinical parameters, age at onset of diabetes showed 
significantly higher odds of having higher SBP and 
DBP implying that older age at onset of T2DM is 
more likely to be associated with higher systolic and 
diastolic blood pressure values. 
Major strength of this study is the inclusion of 
patients at different ages of diabetes without com-
mencing any non-pharmacological or pharmacologi-
cal therapy to control lipids, blood pressure or blood 
sugar making them truly newly diagnosed without 
any lifestyle of pharmacological intervention. As our 
findings are derived from a single center, general-
ization of these findings for the population needs 
population based or representative multi center stud-
ies. Inclusion of a majority (71%) of males is a one 
limitation of our study. Although mean SBP and DBP 
levels were higher among females, we could not find 
gender as a significant determinant of any CVD risk 
factor except for lower HDL in males on logistic re-
gression. Smaller proportion of females (29%) includ-
ed could have affected the findings of  this study. 
Conclusion
In summary, findings of this study highlight three 
major patterns of CVD risk factors prevalent among 
patients at the time of diagnosis of T2DM. Of them, 
the therapeutically most relevant finding is the need 
to initiate statin therapy in eight out of ten patients at 
the time of diagnosis for primary prevention of CVD. 
The other two observations include the statistically 
significant associations of atherogenic dyslipidemia 
with lower HDL and higher TG levels with younger 
age at onset of diabetes and male gender.  Finding 
of both SBP and DBP having a statistically significant 
association with increasing age at the time of diag-
nosis of diabetes is expected as both forms of blood 
pressure are known to rise with advancing age.  
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